DTST vs. SRPT

Last updated Jun 4, 2026

DTST (Data Storage Corporation) and SRPT (Sarepta Therapeutics, Inc.) are both stocks. DTST operates in Information Technology Services (Technology), while SRPT operates in Biotechnology (Healthcare). Over the past 10 years, DTST returned 14.43%/yr vs 0.42%/yr for SRPT. At a 0.05 correlation, their price movements are largely independent.

Performance

DTST vs. SRPT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Data Storage Corporation (DTST) and Sarepta Therapeutics, Inc. (SRPT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DTST achieves a -30.86% return, which is significantly lower than SRPT's -24.54% return. Over the past 10 years, DTST has outperformed SRPT with an annualized return of 14.43%, while SRPT has yielded a comparatively lower 0.42% annualized return.

DTST

• 1D: -1.39%
• 1M: -11.28%
• YTD: -30.86%
• 6M: -19.36%
• 1Y: -6.35%
• 3Y*: 22.41%
• 5Y*: -7.72%
• 10Y*: 14.43%

SRPT

• 1D: -0.06%
• 1M: -26.32%
• YTD: -24.54%
• 6M: -25.64%
• 1Y: -58.22%
• 3Y*: -49.37%
• 5Y*: -25.96%
• 10Y*: 0.42%

*Multi-year figures are annualized to reflect compound growth (CAGR)

DTST vs. SRPT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
DTST Data Storage Corporation	-30.86%	21.04%	46.87%	94.59%	-51.63%	-45.74%	17.50%	-14.29%	96.08%	27.50%
SRPT Sarepta Therapeutics, Inc.	-24.54%	-82.30%	26.09%	-25.58%	43.90%	-47.18%	32.12%	18.24%	96.14%	102.84%

Correlation

The correlation between DTST and SRPT is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.13
Correlation (10Y) Calculated over the trailing 10-year period	0.07
Correlation (All Time) Calculated using the full available price history since Sep 21, 2010	0.05

Fundamentals

Market Cap DTST : $25.75M SRPT : $1.98B
EPS DTST : $2.61 SRPT : $0.60
PE Ratio DTST : 1.35 SRPT : 27.06
PS Ratio DTST : 18.81 SRPT : 0.81
PB Ratio DTST : 0.63 SRPT : 1.32
Total Revenue (TTM) DTST : $1.38M SRPT : $2.18B
Gross Profit (TTM) DTST : $614.32K SRPT : $751.34M
EBITDA (TTM) DTST : -$3.57M SRPT : $107.91M

Return for Risk

DTST vs. SRPT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DTST

DTST Risk / Return Rank: 38
DTST Sharpe Ratio Rank: 37
DTST Sortino Ratio Rank: 41
DTST Omega Ratio Rank: 40
DTST Calmar Ratio Rank: 34
DTST Martin Ratio Rank: 35

SRPT

SRPT Risk / Return Rank: 17
SRPT Sharpe Ratio Rank: 16
SRPT Sortino Ratio Rank: 22
SRPT Omega Ratio Rank: 21
SRPT Calmar Ratio Rank: 10
SRPT Martin Ratio Rank: 18

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DTST vs. SRPT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Data Storage Corporation (DTST) and Sarepta Therapeutics, Inc. (SRPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DTST	SRPT	Difference
Sharpe ratio Return per unit of total volatility	-0.09	-0.56	+0.47
Sortino ratio Return per unit of downside risk	0.46	-0.36	+0.81
Omega ratio Gain probability vs. loss probability	1.06	0.94	+0.11
Calmar ratio Return relative to maximum drawdown	-0.19	-0.81	+0.62
Martin ratio Return relative to average drawdown	-0.35	-1.08	+0.73
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DTST vs. SRPT - Sharpe Ratio Comparison

The current DTST Sharpe Ratio is -0.09, which is higher than the SRPT Sharpe Ratio of -0.56. The chart below compares the historical Sharpe Ratios of DTST and SRPT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	DTST	SRPT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.09	-0.56	+0.47
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.10	-0.37	+0.28
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.07	0.01	+0.06
Sharpe Ratio (All Time) Calculated using the full available price history	0.04	-0.03	+0.07

Drawdowns

DTST vs. SRPT - Drawdown Comparison

The maximum DTST drawdown since its inception was -98.95%, roughly equal to the maximum SRPT drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for DTST and SRPT.

Drawdown Indicators

	DTST	SRPT	Difference
Max Drawdown Largest peak-to-trough decline	-98.95%	-98.17%	-0.78%
Max Drawdown (1Y) Largest decline over 1 year	-33.21%	-72.26%	+39.05%
Max Drawdown (3Y) Largest decline over 3 years	-61.84%	-92.72%	+30.88%
Max Drawdown (5Y) Largest decline over 5 years	-85.19%	-92.72%	+7.53%
Max Drawdown (10Y) Largest decline over 10 years	-95.13%	-93.33%	-1.80%
Current Drawdown Current decline from peak	-94.10%	-90.91%	-3.19%
Average Drawdown Average peak-to-trough decline	-81.04%	-68.14%	-12.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.32%	54.00%	-35.68%

Volatility

DTST vs. SRPT - Volatility Comparison

The current volatility for Data Storage Corporation (DTST) is 15.16%, while Sarepta Therapeutics, Inc. (SRPT) has a volatility of 17.02%. This indicates that DTST experiences smaller price fluctuations and is considered to be less risky than SRPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DTST	SRPT	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.16%	17.02%	-1.86%
Volatility (6M) Calculated over the trailing 6-month period	33.68%	52.59%	-18.91%
Volatility (1Y) Calculated over the trailing 1-year period	70.55%	103.50%	-32.95%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	79.81%	69.81%	+10.00%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	216.10%	70.75%	+145.35%

Dividends

DTST vs. SRPT - Dividend Comparison

Neither DTST nor SRPT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

DTST vs. SRPT - Profitability Comparison

The chart below illustrates the profitability comparison between Data Storage Corporation and Sarepta Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

DTST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Data Storage Corporation reported a gross profit of -4.98M and revenue of -12.26M. Therefore, the gross margin over that period was 40.6%.

SRPT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sarepta Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 730.80M. Therefore, the gross margin over that period was 0.0%.

DTST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Data Storage Corporation reported an operating income of -1.59M and revenue of -12.26M, resulting in an operating margin of 12.9%.

SRPT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sarepta Therapeutics, Inc. reported an operating income of 358.43M and revenue of 730.80M, resulting in an operating margin of 49.1%.

DTST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Data Storage Corporation reported a net income of 3.14M and revenue of -12.26M, resulting in a net margin of -25.6%.

SRPT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sarepta Therapeutics, Inc. reported a net income of 330.96M and revenue of 730.80M, resulting in a net margin of 45.3%.

Frequently Asked Questions

Can I hold both DTST and SRPT in my portfolio?

DTST and SRPT have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, DTST or SRPT?

SRPT has higher volatility (17.02%) compared to DTST (15.16%). In terms of maximum drawdown, DTST dropped -98.95% vs SRPT's -98.17%.

Which has better risk-adjusted returns?

DTST currently has the higher Sharpe Ratio (-0.09 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.